Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study
Status:
Unknown status
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine whether a pre-treatment with high-dose statin (one day
prior and just before intervention, rosuvastatin 20mg/day) has a positive impact on the
occurrence of periprocedural myocardial infarction during percutaneous coronary intervention
(PCI).